Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00092586
Status:
COMPLETED
Last Update Posted:
2022-02-15
First Post:
2004-09-23
Brief Title:
Study of an Approved Drug With a Statin a Medication That Lowers Cholesterol Levels as Compared to Statin Therapy Alone in Patients With High Cholesterol 0653-040
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Multi-center Double-Blind Randomized Placebo-Controlled Parallel Group 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe 10 mgDay When Added to Ongoing Therapy With a Statin Versus Statin Therapy Alone in Patients With Hypercholesterolemia Who Have Not Reached National Cholesterol Education Program NCEP Adult Treatment Panel ATP III Target LDL-Cholesterol Level
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this 6-week study is to compare the reduction in specific levels of cholesterol in patients with high cholesterol
Detailed Description:
The duration of treatment is 6 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004_037 | None | None | None |